News
FDA Vaccine Chief Steps Down After Controversial Tenure
During his first term, Trump signed the “Right to Try” law, which allows terminally ill patients to seek treatments that haven't been fully approved by the FDA, the AP said. His team also recently rejected three applications for new gene therapies from smaller biotech companies.
DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the ...
Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic of the agency’s COVID-19 policies, has departed after being on the job ...
U.S. health officials have told more than a half-dozen of the nation’s top medical organizations that they will no longer ...
Vinay Prasad, M.D., has left the FDA less than three months into the role as director of the Center for Biologics Evaluation ...
Vinay Prasad is my former student and friend. His departure from FDA is a loss for American medicine
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...
Last month, HHS Secretary Robert F. Kennedy Jr. fired an influential committee of vaccine advisers to the CDC. What that ...
Democrats on the U.S. Senate's health committee launched an investigation on Tuesday into Health Secretary Robert F. Kennedy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback